(Thread) With due respect to others who have contributed to my special edition I consider this one of the most important pieces. bit.ly/2OAa1aH@Altostrata When I was coming off an antidepressant and in dire straits, I could not find any guidance on what was (1/n)
going on or how to navigate out of it from published literature. Without Adele Framer I would not have been able to get off my drugs; indeed I am not sure I would be alive. I have learnt a lot from her and now I am very glad that now other clinicians, patients (2/n)
and researchers will be able to learn from the wisdom she has gained over 15 years and deep study. She tells me she looked and looked for an expert to be able to help her and could not find one. Instead, she was forced to become one herself. (3/n)
I am grateful that she performed the alchemy of turning her suffering into guidance for others.
We should alos ask ourselves why there has been so little interest and expertise in this subject for so long? (4/n)
Why have patients been forced to congregate online to work things out for themselves? If we don’t learn lessons then we are doomed to repeat the same patterns again and again.
She has some very interesting things to say about how to taper slowly, what might happen when (5/n)
people go on and off drugs multiple times, and what a Maine lobster fisherman has in common with a psychiatrist. Many important avenues for further research to try to work out how to more safely take people off psychiatric medications. (6/n)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
If you have been tapered off a psych drug too fast by a doctor, is it possible (after recovering) to go back and try to let them know what happened? Understand there may be a lot of anger. But could help others avoid the same fate. Terrible thing to have ask ppl to do I know
I ask this because in a focus group yesterday some ppl had done this. Know this takes a lot of energy. But ppl need to stop being told 'I have never seen this before', 'I don't know what to do'. At some point I am sure @rcgp will spring into action
It is also a numbers game. There are about 30,000 GPs in England. Based on this paper there are 10,000 English people just on a handful of facebook sites who know how to taper antidepressants. There are more ppl learning all the time bit.ly/3qhgTXb
In the same way that benzos can make anxiety worse in the long term, can antidepressants worsen the condition they are designed to treat? Proud to have commissioned this thoughtful analysis: bit.ly/2GDRMgj@TAPsychopharm /1
Current diagnostic systems in psychiatry do not consider the iatrogenic components of psychopathology, and can be applied to only patients who are drug free. They are suited for a patient who no longer exists: most of the cases that are seen in psychiatric clinical practice.../2
"...receive psychotropic drugs and such treatment is likely to affect prognosis and treatment choices."/3
How to taper antipsychotic medication to minimise withdrawal problems: more slowly than you think, down to fractions of usually used doses. Might need liquid versions, pill cutters. Thks Robin Murray, David Taylor @sameerjauhar Sridhar Natesan @JAMAPsychbit.ly/2XyvtxM
Summary: Antipsychotics can reduce psychotic symptoms and might reduce relapse rates so can be useful. But lots of side effects: tardive dyskinesia, metabolic problems, subjectively unpleasant, probable brain shrinkage. 1/
Doses should therefore be reduced to minimal effective dose, which for some might be zero. Also evidence that functioning (employment, independent living, relationships) improve for less or no antipsychotic /2
Ketamine, like other anaesthetic agents propofol and nitrous oxide, reduces depression scores in 2 hours. Does that make esketamine a safe and effective antidepressant? No. With @joannamoncrieff in @TheBJPsychbit.ly/3gw4cUC (thread)
We analysed studies submitted by Janssen to FDA to licence esketamine (esk) for treatment-resistant depression (TRD). TRD sounds rare and severe, but Janssen’s defn - people who have ‘failed’ two different ADs - likely to include many current AD users. (1/25)
Esk is one of two mirror image molecules that make up ket. Esk is 2xpotent as ket. 3 trials conducted for 4 weeks to compare esk to placebo. In 2 of these trials there was no sig. difference between esketamine and pbo. (2/25)
(thread) An interesting session today on antidepressant withdrawal. Much confusion resolved by looking at how long people are on antidepressants:clear relationship between length of use and risk of withdrawal symptoms.
Whether studies are RCTs, observational or survey data all fit along a curve that increases for increasing duration of use. Hugely misleading to patients and doctors to focus on studies for patients only on 12 weeks of antidepressants
When half of English population is on antidepressants for more than 2 years. In this group of patients all data points to incidence of withdrawal being 50% +. True for escitalopram, fluoxetine as well